Maravai Lifesciences Holdings Inc (MRVI) Stock Rated Neutral by Guggenheim
Guggenheim has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Neutral rating, as announced on December 19, 2024, according to Finviz. Earlier, on December 5, 2024, Goldman had reduced the stock from a Neutral to Sell, setting a price target of $4.25. Wolfe Research also initiated Peer Perform rating. Additionally, William Blair reduced Mkt […]
Uncover the Reason: Why Maravai Lifesciences Holdings Inc (MRVI) Stock Is Trading 18.13% Above Its 52-Week Low?
Guggenheim has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Neutral rating, as announced on December 19, 2024, according to Finviz. Earlier, on December 5, 2024, Goldman had reduced the stock from a Neutral to Sell, setting a price target of $4.25. Wolfe Research also initiated Peer Perform rating. Additionally, William Blair reduced Mkt […]
Maravai Lifesciences Holdings Inc (MRVI) Stock’s -0.03% Decrease This Year: What’s the Story?
Guggenheim has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Neutral rating, as announced on December 19, 2024, according to Finviz. Earlier, on December 5, 2024, Goldman had reduced the stock from a Neutral to Sell, setting a price target of $4.25. Wolfe Research also initiated Peer Perform rating. Additionally, William Blair reduced Mkt […]
Maravai Lifesciences Holdings Inc (MRVI) Stock Settles at $5.32: What’s Contributing to This Price Point?
Guggenheim has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Neutral rating, as announced on December 19, 2024, according to Finviz. Earlier, on December 5, 2024, Goldman had reduced the stock from a Neutral to Sell, setting a price target of $4.25. Wolfe Research also initiated Peer Perform rating. Additionally, William Blair reduced Mkt […]
Maravai Lifesciences Holdings Inc (MRVI) Stock: Surpassing Expectations in the Market?
Guggenheim has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Neutral rating, as announced on December 19, 2024, according to Finviz. Earlier, on December 5, 2024, Goldman had reduced the stock from a Neutral to Sell, setting a price target of $4.25. Wolfe Research also initiated Peer Perform rating. Additionally, William Blair reduced Mkt […]
Stock Shock: The Unpredictable Rise and Fall of MRVI—What’s Driving the Drama?
Guggenheim has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Neutral rating, as announced on December 19, 2024, according to Finviz. Earlier, on December 5, 2024, Goldman had reduced the stock from a Neutral to Sell, setting a price target of $4.25. Wolfe Research also initiated Peer Perform rating. Additionally, William Blair reduced Mkt […]
Maravai Lifesciences Holdings Inc (MRVI) Stock: Analyzing Its Quiet Power
Guggenheim has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Neutral rating, as announced on December 19, 2024, according to Finviz. Earlier, on December 5, 2024, Goldman had reduced the stock from a Neutral to Sell, setting a price target of $4.25. Wolfe Research also initiated Peer Perform rating. Additionally, William Blair reduced Mkt […]
The Maravai Lifesciences Holdings Inc Stock Thriller: Decoding the Mystery Behind MRVI’s Recent Movements
Guggenheim has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Neutral rating, as announced on December 19, 2024, according to Finviz. Earlier, on December 5, 2024, Goldman had reduced the stock from a Neutral to Sell, setting a price target of $4.25. Wolfe Research also initiated Peer Perform rating. Additionally, William Blair reduced Mkt […]
Maravai Lifesciences Holdings Inc (MRVI) Stock Rated Sell by Goldman
Goldman has recently reduced Maravai Lifesciences Holdings Inc (MRVI) stock to Sell rating, as announced on December 5, 2024, according to Finviz. Earlier, on November 14, 2024, Wolfe Research had initiated the stock to Peer Perform. William Blair also reduced Mkt Perform rating. Additionally, Wells Fargo initiated Overweight rating on August 28, 2024, with a […]
Maravai Lifesciences Holdings Inc (MRVI) Stock Dive: The Hidden Causes Revealed
Goldman has recently reduced Maravai Lifesciences Holdings Inc (MRVI) stock to Sell rating, as announced on Today, according to Finviz. Earlier, on November 14, 2024, Wolfe Research had initiated the stock to Peer Perform. William Blair also reduced Mkt Perform rating. Additionally, Wells Fargo initiated Overweight rating on August 28, 2024, with a target price […]
